0
1
+

Patients Treated With an Antidepressant

  • Optimizing (i.e., raising) the dose is a reasonable first step if side-effect burden is tolerable, especially if the upper dosage limit has not yet been reached.

  • Some patients may require doses higher than those approved by the Food and Drug Administration.

  • In patients who have shown a partial response, particularly those who have features of personality disorders and prominent psychosocial stressors, extending the antidepressant medication trial (e.g., by 4–8 weeks, but not indefinitely) can be considered.

+

Patients Treated With Psychotherapy

  • As for patients treated with an antidepressant, an initial strategy is to increase the intensity of treatment (i.e., increase the frequency of psychotherapy sessions).

  • The appropriateness of the type of psychotherapy used and the quality of the therapeutic alliance should be reviewed.

References

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).
Related Content
Articles
Books
Manual of Clinical Psychopharmacology, 7th Edition > Chapter 3.  >
The American Psychiatric Publishing Textbook of Psychiatry, 5th Edition > Chapter 26.  >
Gabbard's Treatments of Psychiatric Disorders, 4th Edition > Chapter 23.  >
Gabbard's Treatments of Psychiatric Disorders, 4th Edition > Chapter 24.  >
Gabbard's Treatments of Psychiatric Disorders, 4th Edition > Chapter 26.  >
Psychiatric News
PubMed Articles
The toll of untreated depression. Johns Hopkins Med Lett Health After 50 2014;29(3):1-2.
Clinical practice: Obsessive-compulsive disorder. N Engl J Med 2014;371(7):646-53.
 
  • Print
  • PDF
  • E-mail
  • Chapter Alerts
  • Get Citation